Nina Herne
CEO
Virdings allé 32B, Uppsala
SE-754 50, Sweden
Phone: +46 (0) 70-7147457
Email: nina.herne@lidds.se
Jenni Björnulfson
CFO
Virdings allé 32B, Uppsala
SE-754 50, Sweden
Phone: +46 (0) 70-8553805
Email: jenni.bjornulfson@liddspharma.com
Lidds
LIDDS develops effective pharmaceutical products for cancer and other diseases with the patented NanoZolid® technology. NanoZolid releases the medication locally and effectively which means significantly fewer side effects compared with systemic treatment allowing a controlled, sustained and customized release of medication for up to six months.
Visitingadress: Virdings allé 32b, Uppsala
SE-754 50, Sweden. +46 00 44 55 66 info@liddspharma.com
Financial Calendar
Subscribe for news
Press releases
LIDDS presenterar vid Redeye Fight Cancer seminarium
LIDDS presents at Redeye Fight Cancer SeminarLIDDS AB (publ) Org No.: 556580-2856, Virdings allé 32B, 754 50 UPPSALA, www.liddspharma.com
